ARK Genomic Revolution ETF vs ThredUp Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.49, while ThredUp Inc trades at $6.13 (market cap $850.38M). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, ThredUp Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | TDUP | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $12.08 |
52-Week Low | $23.09 | $3.11 |
Market Cap | — | $850.38M |
Enterprise Value | — | $853.11M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ThredUp (TDUP) trades at $6.18, down 6.36% over 24 hours, with a bullish technical signal from moving averages. The company reported Q1 2026 revenue of $81.7 million, a 15% year-over-year increase, and a net loss of $0.05 per share, meeting expectations. Analyst consensus is bullish with a $6.90 price target, supported by recent initiatives like AI integration and a new peer-to-peer marketplace launch.
The outlook hinges on execution of growth initiatives and path to profitability. Opportunities include expanding gross margins and leveraging AI for efficiency, while risks involve persistent net losses and competitive pressures in online resale. Cash flow trends show improvement, but shareholder equity remains pressured by accumulated deficits.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app, and RaaS partners.
Read more on TDUP →